Accuracy and feasibility of an android-based digital assessment tool for post stroke visual disorders - The StrokeVision App

Background: Visual impairment affects up to 70% of stroke survivors. We designed an app (StrokeVision) to facilitate screening for common post stroke visual issues (acuity, visual fields and visual inattention). We sought to describe the test-time, feasibility, acceptability and accuracy of our app based digital visual assessments against a) current methods used for bedside screening, and b) gold standard measures. Methods: Patients were prospectively recruited from acute stroke settings. Index tests were app based assessments of fields and inattention performed by a trained researcher. We compared against usual clinical screening practice of visual fields to confrontation including inattention assessment (simultaneous stimuli). We also compared app to gold standard assessments of formal kinetic perimetry (Goldman or Octopus Visual Field Assessment); and pencil and paper based tests of inattention (Albert’s, Star Cancellation, and Line Bisection). Results of inattention and field tests were adjudicated by a specialist Neuro-Ophthalmologist. All assessors were masked to each other’s results. Participants and assessors graded acceptability using a bespoke scale that ranged from 0 (completely unacceptable) to 10 (perfect acceptability). Results: Of 48 stroke survivors recruited, the complete battery of index and reference tests for fields was successfully completed in 45. Similar acceptability scores were observed for app-based (assessor median score 10 [IQR:9-10]; patient 9 [IQR:8-10]) and traditional bedside testing (assessor 10 [IQR:9-10; patient 10 [IQR:9-10]). Median test time was longer for app-based testing (combined time-to-completion of all digital tests 420 seconds [IQR:390-588]) when compared with conventional bedside testing (70 seconds, [IQR:40-70]) but shorter than gold standard testing (1260 seconds, [IQR:1005-1620]). Compared with gold standard assessments, usual screening practice demonstrated 79% sensitivity and 82% specificity for detection of a stroke-related field defect. This compares with 79% sensitivity and 88% specificity for StrokeVision digital assessment. Conclusion: StrokeVision shows promise as a screening tool for visual complications in the acute phase of stroke. The app is at least as good as usual screening and offers other functionality that may make it attractive for use in acute stroke

Exercise Beliefs During Pregnancy in a Predominantly Low-Income, Urban Minority Population

In 2002, and reaffirmed in 2009, The American College of Obstetricians and Gynecologists recommended that healthy pregnant women exercise for at least thirty minutes most days of the week. Exercise during a healthy pregnancy is safe and has many maternal and fetal benefits. Identified benefits include management of weight gain, improvement in mood, and preparation for labor. Previous research has evaluated women’s beliefs and practices of exercise in pregnancy, but it has focused on affluent, ethnic majority populations. This survey study was performed to assess beliefs about exercise in pregnancy in a predominantly low-income, urban minority population.https://jdc.jefferson.edu/cwicposters/1031/thumbnail.jp

Quick Reference Guide, Best Practice Statement for Screening, Assessment and Management of Vision Problems in the First 30 Days After an Acute Stroke

No abstract available

Quick Reference Guide, Best Practice Statement for Screening, Assessment and Management of Vision Problems in the First 30 Days After an Acute Stroke

No abstract available

Outcomes, experiences and palliative care in major stroke:a multicentre, mixed-method, longitudinal study

Background: Case fatality after total anterior circulation stroke is high. Our objective was to describe the experiences and needs of patients and caregivers, and to explore whether, and how, palliative care should be integrated into stroke care. Methods: From 3 stroke services in Scotland, we recruited a purposive sample of people with total anterior circulation stroke, and conducted serial, qualitative interviews with them and their informal and professional caregivers at 6 weeks, 6 months and 1 year. Interviews were transcribed for thematic and narrative analysis. The Palliative Care Outcome Scale, EuroQol-5D-5L and Caregiver Strain Index questionnaires were completed after interviews. We also conducted a data linkage study of all patients with anterior circulation stroke admitted to the 3 services over 6 months, which included case fatality, place of death and readmissions. Results: Data linkage (n = 219) showed that 57% of patients with total anterior circulation stroke died within 6 months. The questionnaires recorded that the patients experienced immediate and persistent emotional distress and poor quality of life. We conducted 99 interviews with 34 patients and their informal and professional careers. We identified several major themes. Patients and caregivers faced death or a life not worth living. Those who survived felt grief for a former life. Professionals focused on physical rehabilitation rather than preparation for death or limited recovery. Future planning was challenging. “Palliative care” had connotations of treatment withdrawal and imminent death. Interpretation: Major stroke brings likelihood of death but little preparation. Realistic planning with patients and informal caregivers should be offered, raising the possibility of death or survival with disability. Practising the principles of palliative care is needed, but the term “palliative care” should be avoided or reframed

Home-Time Is a Feasible and Valid Stroke Outcome Measure in National Datasets

Background and Purpose— Home-time (HT) is a stroke outcome measure based on time spent at home after stroke. We hypothesized that HT assessment would be feasible and valid using national data. Methods— We linked the Scottish Stroke Care Audit to routine healthcare data and calculated 90-day HT for all strokes, 2005 to 2017. We described prognostic validity (Spearman rank correlation) of HT to baseline factors. Results— We were able to calculate HT for 101 969 strokes (99.3% of total Scottish strokes). Mean HT was 46 days (95% CI, 45.8–46.2; range, 0–90). HT showed consistent correlation with our prespecified prognostic factors: age: ρ, −0.35 (95% CI, −0.35 to −0.36); National Institutes of Health Stroke Scale score, −0.54 (95% CI, −0.52 to −0.55); and 6 simple variables (ordinal), −0.61 (95% CI, −0.61 to −0.62). Conclusions— HT can be derived at scale using routine clinical data and appears to be a valid proxy measure of functional recovery. Other national databases could use HT as a time and cost efficient measure of medium and longer-term outcomes

Piezoelectric Ribbons Printed onto Rubber for Flexible Energy Conversion

The development of a method for integrating highly efficient energy conversion materials onto stretchable, biocompatible rubbers could yield breakthroughs in implantable or wearable energy harvesting systems. Being electromechanically coupled, piezoelectric crystals represent a particularly interesting subset of smart materials that function as sensors/actuators, bioMEMS devices, and energy converters. Yet, the crystallization of these materials generally requires high temperatures for maximally efficient performance, rendering them incompatible with temperature-sensitive plastics and rubbers. Here, we overcome these limitations by presenting a scalable and parallel process for transferring crystalline piezoelectric nanothick ribbons of lead zirconate titanate from host substrates onto flexible rubbers over macroscopic areas. Fundamental characterization of the ribbons by piezo-force microscopy indicates that their electromechanical energy conversion metrics are among the highest reported on a flexible medium. The excellent performance of the piezo-ribbon assemblies coupled with stretchable, biocompatible rubber may enable a host of exciting avenues in fundamental research and novel applications

The variation in acute and community service provision of care of the elderly services across the Scotland: Findings from the Scottish Care of Older People (SCoOP) National Audit initial scoping survey

We gratefully acknowledge the support of the British Geriatrics Society (BGS) in raising awareness of this work and the BGS Scotland Council for dissemination of the scoping survey. We also would like to thank Mr Tiberiu Pana, Mr Jesus Perdomo, Dr Maryam Barma and Dr Adrian Wood for their assistance with the project. We would also like to thank the SCoOP Steering Committee Members and Dr Claire Copeland (NHS Forth Valley) for their contribution. The SCoOP Steering Group includes: Dr Louise Beveridge (NHS Tayside), Professor Corri Black (University of Aberdeen), Ms Penny Bond (Healthcare Improvement Scotland), Dr Jennifer Burns (NHS Greater Glasgow and Clyde), Dr Tony Byrne (NHS Forth Valley), Dr Andrew Coull (NHS Lothian), Dr Alison Donaldson (University of Aberdeen), Dr Alice Einarsson (NHS Grampian), Professor Graham Ellis (NHS Lanarkshire, Glasgow Caledonian University and Co-Chair), Ms Karen Goudie(Healthcare Improvement Scotland) , Dr Graeme Hoyle (NHS Grampian), Dr Allan MacDonald (NHS Highland), Dr Christine McAlpine (NHS Greater Glasgow and Clyde), Dr Morven McElroy (NHS Greater Glasgow and Clyde), Professor Phyo Kyaw Myint (University of Aberdeen, Co-Chair), Dr Terence J Quinn (University of Glasgow), Professor Sir Lewis Ritchie (University of Aberdeen), Dr Susan Shenkin (University of Edinburgh), Dr Ralph Thomas (NHS Fife) and Dr Andrew Watt (NHS Ayrshire and Arran).Peer reviewedPublisher PD

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Background Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy